Supreme Court ruling raises drug pricing concerns in India
pre-market1 source ↓written by the desknot a recommendation
A recent Supreme Court ruling has ignited discussions on drug pricing regulation in India. Advocates warn that high prices may limit access to essential medications, impacting public health equity. Health activists fear potential price increases could adversely affect millions dependent on affordable drugs, urging policies that prioritize accessibility over profits.
Not investment advice. For informational purposes only.